Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Preparation of Nanoparticle Suspensions

Posted on By

SOP for Preparation of Nanoparticle Suspensions

Standard Operating Procedure for Preparation of Nanoparticle Suspensions

1) Purpose

This SOP outlines the procedure for preparing stable nanoparticle suspensions used in drug delivery, diagnostics, and other applications. The goal is to ensure that nanoparticles are uniformly dispersed in the suspension and maintain stability over time.

2) Scope

This SOP applies to laboratory personnel responsible for the preparation of nanoparticle suspensions in a sterile and controlled environment.

3) Responsibilities

  • Operators: Responsible for following the SOP to prepare stable nanoparticle suspensions.
  • QA: Ensures that nanoparticle suspensions meet the required size, stability, and quality parameters.
See also  SOP for Lyophilization of Nanoparticle-Based Formulations

4) Procedure

4.1 Preparation of Nanoparticles

4.1.1 Nanoparticle Selection

  • 4.1.1.1 Select the desired type of nanoparticles based on the specific application (e.g., polymeric, metallic, or lipid-based nanoparticles).

4.2 Preparation of Suspension Medium

4.2.1 Solvent Selection

  • 4.2.1.1 Prepare a suspension medium using distilled water, saline solution, or a buffer depending on the application.

4.2.2 Stabilizers

  • 4.2.2.1 Add a stabilizer (e.g., PVA, Tween 80) to the suspension medium to prevent nanoparticle aggregation.

4.3 Suspending the Nanoparticles

4.3.1 Dispersion

  • 4.3.1.1 Add the nanoparticles to the suspension medium under gentle stirring.
  • 4.3.1.2 Use an ultrasonic bath or homogenizer to ensure uniform dispersion of the nanoparticles in the suspension.
See also  SOP for Nanoencapsulation Techniques for Drug Delivery

4.3.2 Monitoring Particle Size

  • 4.3.2.1 Measure the particle size using dynamic light scattering (DLS) to ensure the nanoparticles remain in
the desired size range (typically less than 200 nm).

4.4 Storage and Stability Testing

4.4.1 Storage

  • 4.4.1.1 Store the nanoparticle suspension in sterile, sealed containers at 4°C.

4.4.2 Stability Testing

  • 4.4.2.1 Periodically test the suspension for particle size, zeta potential, and any signs of aggregation or sedimentation.

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering
  • PVA: Polyvinyl Alcohol

6) Documents, if any

  • Nanoparticle Suspension Preparation Logbook

7) References, if any

  • Relevant literature on the preparation and stabilization of nanoparticle suspensions

8) SOP Version

Version 1.0

Annexure

Nanoparticle Suspension Preparation Logbook Template

Date Batch Number Particle Type Particle Size Stabilizer Used Operator Initials QA Initials
DD/MM/YYYY Batch Number Type of Nanoparticles Size in nm Stabilizer Name Operator Name QA Name
           
See also  Nanoparticle Formulation : SOP for Use of Surfactants in Nanoparticle Formulations
Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

Post navigation

Previous Post: SOP for Formulation of Nasal Drops
Next Post: SOP for Mixing and Homogenization Techniques in Lyophilized Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version